Infection, Tumors and Autoimmunity: Report on the 11th Dresden Symposium on Autoantibodies held in Dresden on September 1-4, 2013 AUTOANTIGENS, AUTOANTIBODIES, AUTOIMMUNITY Volume 9 - 2013 - Erstausgabe

EAN (ISBN-13): 9783899678819
ISBN (ISBN-10): 3899678818
Erscheinungsjahr: 2013
Herausgeber: Conrad, K. Chan, E.K.L. Fritzler, M.J. Pabst Science Publishers

Buch in der Datenbank seit 2014-09-28T19:45:04+02:00 (Vienna)
Detailseite zuletzt geändert am 2023-11-27T16:17:50+01:00 (Vienna)
ISBN/EAN: 9783899678819

ISBN - alternative Schreibweisen:
3-89967-881-8, 978-3-89967-881-9
Alternative Schreibweisen und verwandte Suchbegriffe:
Autor des Buches: fritzler
Titel des Buches: infection

---

Daten vom Verlag:

Autor/in: K. Conrad; E.K.L. Chan; M.J. Fritzler; R.L. Humbel; P.L. Meroni; G. Steiner; Y. Shoenfeld
Titel: Autoimmunity, autoantigens, autoantibodies; Infection, Tumors and Autoimmunity - Report on the 11th Dresden Symposium on Autoantibodies held in Dresden on September 1-4, 2013 AUTOANTIGENS, AUTOANTIBODIES, AUTOIMMUNITY Volume 9 - 2013
Verlag: Pabst Science Publishers
380 Seiten
Erscheinungsjahr: 2013-10-03
DE
Sprache: Englisch
20,00 € (DE)
20,00 € (AT)
28,90 CHF (CH)
Available

EA; E107; Nonbooks, PBS / Medizin/Klinische Fächer; Klinische und Innere Medizin; Verstehen; Infection; Tumor; Liver Diseases; Arthritis; Neurology; Gastrointestinal Diseases; Rheuma; Autoimmunity

Chapter 1 Infections, Tumors and Autoimmunity Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) Carlo Perricone, Yehuda Shoenfeld Possible role of infections in the pathogenesis of autoimmune liver diseases Daniel S. Smyk and Dimitrios P. Bogdanos GP2 – The link between innate and acquired immune system in the intestine Dirk Roggenbuck, Dirk Reinhold, Dimitrios P. Bogdanos, Karsten Conrad Vitamin D in infection and autoimmunity E. Borella, Y. Shoenfeld Clinical implications of anti-rods and rings autoantibodies in hepatitis C patients treated with interferon/ribavirin therapy S. John Calise, Wendy C. Carcamo, and Edward K.L. Chan The hyperferritinemic syndrome in infection and autoimmunity Cristina Rosário, Yehuda Shoenfeld The fate of the Ro autoantigen-associated Y RNAs in Coxsackievirus-infected cells Ger J.M. Pruijn, Dirk den Braanker, Qian Feng, Frank J. van Kuppeveld Autoantibodies to tumor-associated antigens (TAAs) as biomarkers in the immunodiagnosis of cancer Liping Dai, Pengfei Ren, Xinxin Liu, Carlos A. Casiano, Jian-Ying Zhang Immunoproteomic profiling of autoantibodies in prostate cancer: a health disparities perspective Tino W. Sanchez, Anamika Basu, Saied Mirshahidi, Chen Chien-Shing, Susanne Montgomery, Colwick Wilson, Jianying Zhang, Nathan Wall and Carlos A. Casiano Characterisation of novel autoantibody biomarkers in oncology and autoimmunity Will Colón, Colin Wheeler, Ezam Uddin, Nicholas Workman, Pooja Agashe, Tim Vyse and Michael B. McAndrew Chapter 2 Pathogenesis and Therapy of Autoimmune Diseases – Novel Aspects The role of neutrophil extracellular traps (NETs) in autoimmunity and generation of autoantibodies Elaine F. Kenny & Arturo Zychlinsky Revisiting the cell death paradigm in systemic autoimmune diseases Felipe Andrade NETs and ANCA-associated vasculitides Elena Csernok Towards understanding the pathogenesis of granulomatosis with polyangiitis: The role of neutrophil extracellular traps C. Lange, E. Csernok, J.U. Holle Aggregation of NETs: flipping the switch to resolution of inflammation Christine Schorn, Luis Munoz, Deborah Kienhöfer, Martin Herrmann, and Markus Hoffmann Memory plasma cells in autoimmunity – An update Falk Hiepe Protective natural autoantibodies in atherogenesis and autoimmunity Gregg J. Silverman and Caroline Grönwall The interface between primary immunodeficiency and systemic lupus erythematosus Sandro F. Perazzio, Magda Carneiro-Sampaio, Luis E.C. Andrade Inherited defects in nucleic acid metabolism and autoimmunity Stefanie Kretschmer, Nadja König, Min Ae Lee-Kirsch Induction of autoimmunity by defects of intracellular nucleases: Mouse models for Aicardi-Goutières syndrome Axel Roers Anti-AT1R and anti-ETAR autoantibodies from patients with SSc and their agonistic effects A. Kill, Christoph Tabeling, Anja A. Kühl, J. Günther, M.O. Becker, Harald Heidecke, D. Dragun, G.R. Burmester, G. Riemekasten The use of Aptamers as a new tool for the treatment of autoantibody associated diseases G. Wallukat, A. Haberland, S. Berg, E.J. Freyse, E. Salzsieder, W. Schulze, I. Schimke Harnessing parasitic infection to treat autoimmunity Miri Blank, Lachnish Jordan, Bashi Tomer and Yehuda Shoenfeld Chapter 3 Immune Reactions against Drugs Clinical relevance of anti-drug antibodies Arno Kromminga Mycophenolic acid and ribavirin induce cytoplasmic Rods and Rings (RR) structures in vivo, but only ribavirin induces anti-RR autoantibodies Gerson D. Keppeke, Sandro F. Perazzio, Monica S. Prado, Edward K.L. Chan, Luis Eduardo C. Andrade Effects of intracellular glutamine levels on the reversible assembly of cytoplasmic rod and ring autoantigenic structures S. John Calise, Wendy C. Carcamo, Claire Krueger, Daniel L. Purich, and Edward K.L. Chan Chapter 4 Autoantibodies in Systemic Autoimmune Rheumatic Diseases 4.1 Connective Tissue Diseases Anti-Mup44 autoantibodies in inclusion-body myositis Helma Pluk, Megan Herbert, Judith Stammen-Vogelzangs, Baziel G. van Engelen, Ger J.M. Pruijn Autoantibody profiling in idiopathic inflammatory myopathies: Validation of the myositis antigens Mi-2a, MDA5, NXP2 and SAE1 in a line immune assay L. Komorowski, W. Meyer, T. Scheper, W. Schlumberger, A. Ott, P.J. Charles, C. Probst Evaluation of recombinant TIF1-γ in a line immune assay for the detection of autoantibodies in idiopathic inflammatory myopathies C. Probst, L. Komorowski, W. Meyer, T. Scheper, A. Ott, P.J. Charles, K. Danko, L. Bodoky, H. Chinoy, W. Schlumberger Autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) a novel biomarker for statin associated necrotizing myopathies Makoto Miyara, Olivier Benveniste, Jean-Luc Charuel, Alexander Shikhman, Olivier Boyer, Joe Philips, Lucile Musset, Michael Mahler Autoantibody signatures of connective tissue disease patients identified with a bead-based assays approach Angelika Lueking, Petra Budde, Heike Goehler, Jessica Schwermann, Martin Gamer, Klaus Marquardt, Anna Telaar, Daniel Chamrad, Carmen Theek, Matthias Schneider, Peter Schulz-Knappe Identification of novel autoantibody signatures reflecting the heterogeneity in systemic lupus erythematosus P. Budde, A. Lueking, S. Vordenbäumen, H. Göhler, M. Gamer, K. Marquardt, A. Telaar, D. Chamrad, C. Theek, B. Ostendorf, P. Schulz-Knappe, M. Schneider What is the clinical significance of anti-Sm-antibodies in SLE patients? A comparison with anti-dsDNA-antibodies and C3 Alexandra Richartz, Thomas Rose, Cornelia Dähnrich, Anke Rosemann, Fidan Barkhudarova, Wolfgang Schlumberger, Gerd-Rüdiger Burmester, Karl Egerer, Robert Biesen and Falk Hiepe Clinical evaluation of total and high avidity anti-dsDNA antibody EIA for the diagnosis of systemic lupus erythematosus Pengjie Wan, Shuxia Zhou, Hua Cao, Weiping Li, Doug Scott, Joel Hardy, Tony Presitigiacomo, Jie Zheng Significance of anti-C1q antibody detection in SLE patients with lupus nephritis Ivana Stiborová, Vlastimil Král, Stanislava Blažíčková 4.2 Rheumatoid Arthritis Autoantibodies in rheumatoid arthritis: predictors of disease, prognosticators of outcome and pathogenic players Markus Hoffmann, Karin Lundberg and Günter Steiner Antibodies against carbamylated proteins in different stages of rheumatoid arthritis Leendert A. Trouw Development and initial use of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides in rheumatoid arthritis patients Johan Rönnelid, Linda Mathsson, Mats Nystrand, Lars Klareskog, Monika Hansson The anti-CCP2 is the anti-citrullinated protein antibody (ACPA) with highest diagnostic value in rheumatoid arthritis E. Grenmyr and Y. Sommarin Occurrence of anti-RA33 antibody in various types of juvenile idiopathic arthritis Gabor Nagy, Barbara Szasz, Diana Garan, Ibolya Szollosi, Sandor Sipka, Tamas Constantin MMP-3 is a marker for disease activity in rheumatoid arthritis S. Reuter, T. Matthias The conversion of QuantiFERON TB Gold test during biological treatment by anti-TNF preparations E. Zanova, D. Kozakova, I. Rybar, I. Solovic, J. Rovensky Interferon-gamma and QuantiFERON-TB Gold test conversion during biological treatment D. Kozakova, E. Zanova, I. Rybar, I. Solovic, J. Rovensky Chapter 5 Autoantibodies in Organ Specific Diseases 5.1 Neurological Diseases New antibodies in multiple sclerosis Bernhard Hemmer Identification of coronin-1a as a novel antibody target for clinically isolated syndrome and multiple sclerosis Myrthe Rouwette, Jean-Paul Noben, Jack Van Horssen, Bart Van Wijmeersch, Raymond Hupperts, Peter J. Jongen, Marcel M. Verbeek, Peter P. De Deyn, Piet Stinissenand Veerle Somers Diagnostic and pathophysiologic relevance of autoantibodies against aquaporin-4 F. Paul, B. Wildemann, S. Jarius Autoantibodies against the neuronal surface antigen DPPX: markers for an emerging neurological disease entity Bettina Balint, Simon Nagel, Uwe Haberkorn, Christian Probst, Inga-Madeleine Blöcker, Bianca Teegen, Kristin Rentzsch, Ramona Bahtz, Lars Komorowski, Sandra Saschenbrecker, Andreas Kastrup, Martin Kuthe, Hans-Michael Meinck, Winfried Stöcker Nonradioactive determination of autoantibodies against acetylcholine receptors in myasthenia gravis: A new enzyme-linked immunoassay for manual and automated processing J. Westermann, E. Denczyk, C. Probst, L. Komorowski, W. Schlumberger Generation of stable HEp-2 cell line M4 expressing human muscle-specific kinase for automatic videoscan-based immunofluorescence diagnostics of Myasthenia gravis S. George, S. Paulick, I. Knütter, N. Röber, R. Hiemann, D. Roggenbuck, K. Conrad and J.-H. Küpper Clinical validation of a novel immunofluorescence assay for the detection of anti-MuSK antibodies based on MuSK transfected HEp-2 cells Nadja Röber, Silke Weber, Jochen Schäfer, Sandra George, Ilka Knütter, Dirk Roggenbuck, Jan-Heiner Küpper, Karsten Conrad Pleural mesothelioma and anti-MA2-associated encephalitis Adriano Jiménez-Escrig, Silvia Medina, Ángela Carrasco What should be the cut-off for VGKC complex antibodies? Sylvie Coito, Réné-Louis Humbel Multi-center validation study of DNER as the target of anti-PCA-Tr autoantibodies associated with paraneoplastic neurological syndrome Kristin Rentzsch, Inga-Madeleine Blöcker, Bianca Teegen, Winfried Stöcker, Francesc Graus, Véronique Rogemond, Jérome Hônnorat, Esther S.P. Hulsenboom, Peter A.E. Sillevis Smitt, Christian Probst, Lars Komorowski Multi-parametric recombinant cell-based indirect immunofluorescence assay (RC-IFA) for the determination of autoantibodies associated with paraneoplastic neurological syndromes Inga-Madeleine Blöcker, Christiane Radzimski, Mandy Unger, Linda Döring, Winfried Stöcker, Josep Dalmau, Peter Sillevis Smitt, Lars Komorowski, Christian Probst 5.2 Liver and Gastrointestinal Diseases Preliminary report: Detection of antibodies against D-3-phosphoglycerate dehydrogenase (PGDH) in autoimmune liver diseases using a line immune assay W. Meyer, C. Probst, L. Komorowski, A. Ott, T. Scheper, W. Schlumberger, W. Stöcker and H. Yan Can the HEp-2 cell assay replace the indirect immunofluorescence on rat cryostat section for AMA-M2 screening? Kristin Kühnert, Uta Kießling, Teresa Trimpop, Manuela Rejzek, Andrea Thieme, Nadja Röber, Karsten Conrad Prevalence of anti-nuclear antibodies in patients with primary biliary cirrhosis Ana Kozmar, Ivan Padjen, Miroslav Mayer, Mirna Sentic, Branko Malenica Evaluation of a high sensitive assay for the diagnosis of celiac disease Lisbeth Witt, Martin Salden, Klas Sjöberg, Fritz Koning and Yngve Sommarin CytoBead-assay for the simultaneous detection of celiac disease specific antibodies and IgA deficiency Nadja Röber, Kai Grossmann, Ilka Knütter, Rico Hiemann, Mandy Sowa, Martin W. Laass, Karsten Conrad, Dirk Roggenbuck Pancreatic-specific autoantibodies to glycoprotein 2 in pediatric celiac disease Martin W. Laass, Dirk Roggenbuck, Ursula Range, Nadja Röber, Karsten Conrad Comparison of two ELISAs for the detection of anti-MZGP2 antibodies as a new serological marker for Crohn`s disease Laura M. Stinton, Gary L. Norman, Zakera Shums, Maria T. Arias-Loste, Marcos Lopez-Hoyos, Michael Mahler 5.3 Endocrine, Kidney and Skin Diseases Detection of autoimmunity against the insulin-and insulin-like growth factor-1 receptor and their prevalence in humans T. Welsink, C. Schwiebert, W.B. Minich, L. Schomburg Role of autoantibodies anti zinc transporter protein (anti-ZnT8) in the diagnosis and follow-up of type I diabetes mellitus: an Italian experience S. Zago, M. Fabris, P. Melli, M. Zanatta, T. Basso, A. Comici, E. Carlin, G. Zanette, E. Tonutti, A. Rosolen A. Radice Serological profile of idiopathic membranous nephropathy cohort Astrid Behnert, Beina Teng, Janina Müller-Deile, Andrej Skoberne, Mario Schiffer, Marvin J. Fritzler Our experience with anti-phospholipase A2 receptor (PLA2R) indirect immunofluorescence test I. Janatková, M. Hinďoš, Z. Hrušková, B. Svobodová, V. Tesař, K. Malíčková, T. Zima Evaluation of a new ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy W. Schlumberger, C. Dähnrich, C. Probst, B. Seitz-Polski, V. Esnault, J.F. Wetzels, J.M. Hofstra, E. Hoxha, R.A. Stahl, G. Lambeau, W. Stöcker, L. Komorowski Detection of anti-phospholipase A2 receptor autoantibodies: A comparison of three different immunoassays Astrid Behnert, Mario Schiffer, Michael Mahler, Marvin J. Fritzler Anti-M-type Phospholipase A2 Receptor (PLA2r) antibodies in diagnosis and follow-up of idiopathic membranous nephropathy (IMN) S. Glionna, L. Bianchi, B. Trezzi, M. D’Amico, T. Stellato, D. Santoro, R.A. Sinico and A. Radice The antiphospolipid antibodies in psoriasis patients with metabolic syndrome and non-alcoholic fatty liver disease comorbidities N. Virstyuk, M. Volochynovych, M. Nykyforuk Development of sensitive and specific assays for serological diagnosis of anti-laminin 332 mucous membrane pemphigoid S. Groth, A. Abadpour, K. Vafia, C. Probst, L. Komorowski, W. Schlumberger, W. Stöcker, D. Zillikens and E. Schmidt Autoantibodies to Golgi complex and Ro51 protein in non-specific interstitial pneumonia (NSIP): case report and literature review S. Andrejevic, B. Milenkovic, J. Stojsic, R. Stevic, B. Bonaci-Nikolic Chapter 6 Methodical Aspects and Diagnostic Strategies 6.1 New Concepts and Novel Assays New Concepts and Approaches to Autoantibody Testing Laura M. Sinton, Marvin J. Fritzler PR3-ANCA as a promising biomarker for the diagnosis of primary sclerosing cholangitis (PSC) Laura M. Stinton, Chelsea Bentow, Michael Mahler, Gary L. Norman, Bertus Eksteen, Andrew L. Mason, Gilaad G. Kaplan, Bjorn Lindkvist, Angela Cheung, Harry Janssen, Marvin J. Fritzler Standardization of reference material for autoantibody testing: the state of the art Pier Luigi Meroni, Maria Orietta Borghi New diagnostics in autoimmunity: a review and our experience Boris Gilburd, Carlo Perricone, Enrica Cipriano, Nancy Agmon-Levin, Yehuda Shoenfeld Evaluation of a novel sensitive and reliable Lateral Flow Assay (LFA) for the detection of anti-dsDNA antibodies Anti-dsDNA LFA N. Offermann, M. Petschinka and M. Fooke Microtiter plate-based multiparametric assay for detection of non-organ specific autoantibodies Jana Langer, Erik Höchel, Klemens Löster, Martin Eberhardt, Nadja Röber, Karsten Conrad, Silvia Porstmann, Tomas Porstmann CytoBead ANCA -a novel indirect immunofluorescence test for the simultaneous detection of anti-neutrophil cytoplasmic antibodies Mandy Sowa, Ilka Knütter, Rico Hiemann, Kai Grossmann, Nadja Röber, Ursula Anderer, Karsten Conrad, Dirk Reinhold, Elena Csernok, Dirk Roggenbuck Evaluation of ANCA by automated IFA image analysis on NOVA View Carol E. Buchner, Cassandra C. Bryant, Rachel A. Rosenblum, Marlene Gonzalez, Gabriella Lakos Development of a method for multiplex real-time analysis of enzymatic activity on a microbead-chip Stefan Rödiger, Alexander Böhm, Jörg Nitschke, Luba Stavitskaya, Melanie Gruner, Alena V. Kundzer, Margarita V. Volkova, I. Generalov, Carsten Schmidt, Christian Schröder, Dirk Roggenbuck, Peter Schierack 6.2 Antinuclear Antibodies – Diagnostic Strategies and Novel Developments CytoBead – A novel platform for antibody multiplex analyses Rico Hiemann, Mandy Sowa, Kai Grossmann, Ilka Knütter, Juliane Scholz, Nadja Röber, Ursula Anderer, Dirk Reinhold, Peter Schierack, Karsten Conrad, Dirk Roggenbuck Anti-nuclear antibodies: a long way to harmonization Jan Damoiseaux, Nancy Agmon-Levin Standardization of ANA-HEp-2 immunofluorescence pattern nomenclature Wilson M. Cruvinel, Paulo L.C. Francescantonio, Alessandra Dellavance, Luis E.C. Andrade ANA measurement by IIF in comparison to other methods in the diagnosis of connective tissue diseases Xavier Bossuyt Reading and interpretation of ANA immunofluorescence tests: results of a comparative study with six automated systems Nicola Bizzaro, Stefan Platzgummer, Elio Tonutti, Antonio Antico, Danila Bassetti, Danilo Villalta, Fiorenza Pesente, Francesco Cucchiaro, Marilina Tampoia, Renato Tozzoli Efficient autoantibody titration using indirect immunofluorescence assays (IIFA) Jan Martinek, Ivo Lochman, Alexandra Lochmanová, Vladimír Krauz Autoimmunity diagnostic strategies (ANA, anti-dsDNA, anti-ENA) in Italian clinical laboratories A. Radice, L. Bianchi, S. Glionna, B. Trezzi Evaluation of ANA testing results: is there a need for revision of our protocol for antibody specificity testing? Andrea Tesija Kuna, Ines Vukasovic, Nada Vrkic Automation in ANA HEp-2 cells microscopy: can the machine substitute the human eye? Cristovao Pitangueira Mangueira, Eliane Aparecida Rosseto HELIOS, a bright future for ANA -automated indirect immunofluorescence (IIF) assay B. Gilburd, N. Agmon-Levin, T. Martins, A. Petzold, T. Matthias and Y. Shoenfeld Comparability of the AESKUSLIDES ANA-HEp-2 antinuclear antibody (ANA) immunological test system with a commercially available system Torsten Matthias, Sascha Pfeiffer, Trishna Martins, Peter Trinder and Andrea Petzold 92CytoBead ANA -a novel indirect immunofluorescence test for the simultaneous detection of anti-nuclear antibodies Juliane Scholz, Ilka Knütter, Kai Grossmann, Rico Hiemann, Mandy Sowa, Nadja Röber, Karsten Conrad, Peter Schierack, Dirk Roggenbuck Evaluation of a novel chemiluminescent assay (QUANTA Flash® CTD Screen Plus) for the rapid detection of autoantibodies in systemic autoimmune rheumatic diseases C. Bentow, A. Seaman, A. Swart, A. Shikhman, N. Goodman, M. Mahler Quantitative results of automated indirect immunofluorescence enable value added reporting for antinuclear antibody testing Sofie Schouwers, Myriam Bonnet, Patrick Verschueren, René Westhovens, Daniel Blockmans, Godelieve Mariën, Xavier Bossuyt Optimization of the automated HEp-2 cell assay by stepwise improvement of software algorithms Rico Hiemann, Nadja Röber, Dirk Roggenbuck, Karsten Conrad Autoantibodies to mitotic cells René-Louis Humbel Anti-nematin antibodies in practice J. Goetz, R.L. Humbel, G. Uettwiller, F. Habersetzer, M. Doffoel The clinical significance of anti-DFS70 antibodies as part of ANA testing Michael Mahler Prevalence and clinical associations of anti-DFS70 antibodies in samples with high titer of ANA but without detectable fine-specificity Michael Mahler, Sofie Schouwers, Roger Albesa, Eric Tena, Nathalie Vandeputte, Doreen Dillaerts, X. Bossuyt LEDGF/DFS70 antibodies and DFS pattern in routine diagnostics Uwe Höpner, Tim Fülling, Uta Kießling, Teresa Trimpop, Manuela Rejzek, Andrea Thieme, Nadja Röber, Karsten Conrad Longitudinal study of anti-DFS70 antibodies in 5 patients without antinuclear antibody associated autoimmune rheumatic disease Sofie Schouwers, Michael Mahler, Doreen Dilaerts, Nathalie Vandeputte, Xavier Bossuyt Evaluation of the first dot blot assay for the detection of anti DFS 70 antibodies as part of a 12plex ANA Profile Johannes Schulte-Pelkum, Eric Tena, Alain Vigneron, Nicolas Bodart, Michael Mahler Novel autoantibodies showing chromatin binding in the HEp-2 cell assay Angelika Lueking, Heike Goehler, Petra Rengers, Martin Gamer, Klaus Marquardt, Petra Budde, Anna Telaar, Daniel Chamrad, Carmen Theek, Karsten Conrad, and Peter Schulz-Knappe